Migraine Headaches Clinical Trial
Official title:
A Randomized, Double-blind Comparison of Single Dose Prochlorperazine Versus Acetaminophen, Aspirin and Caffeine for the Treatment of Acute Migraine in the Emergency Department.
The objective of this randomized, double blind study is to demonstrate that one dose oral "excedrin migraine" (acetaminophen, aspirin and caffeine) is not inferior when compared to one dose of intravenous prochlorperazine for the treatment of acute migraine headaches in the emergency department.
Patients with severe headaches often come to the emergency department seeking relief from their symptoms. There is some dating suggesting that over the counter treatment options are not inferior to treatment options offered in emergency departments. Patients presenting to the Einstein Emergency Department with IHS criteria for migraine headache will be approached by research associate and offered to participate in a randomized double blind study comparing excedrin migraine to compazine. Patients will be randomized by the hospital pharmacy. The pharmacy will distribute one of two packets, one containing prochlorperazine 10mg and 2 placebo tablets, the other containing 2 generic AAC tablets without scoring (acetaminophen 250mg, aspirin 250mg and caffeine 65mg in each tablet) and a placebo syringe. Patients will be monitored for improvement of pain, change in vital signs, and adverse events for two hours after receiving drugs. At 24 hours, the patients will be called back to access if they experienced any side effects from the time of discharge, and if they would take this medicine again if they experienced another migraine. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06342232 -
The Efficacy of Neurofeedback Mindfulness in Migraine Management
|
N/A | |
Completed |
NCT02351544 -
Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
|
N/A | |
Completed |
NCT00665236 -
Craniosacral Therapy in Migraine: A Feasibility Study
|
N/A | |
Completed |
NCT01706003 -
The Utility of Telemedicine in the Management of Migraine
|
||
Terminated |
NCT01944059 -
Theramine® in the Prevention of Migraine Headache
|
Phase 4 | |
Completed |
NCT00792636 -
A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period
|
Phase 4 | |
Not yet recruiting |
NCT05536635 -
Effect of Breathing Techniques on Migraine Attacks and Severity
|
N/A | |
Completed |
NCT00442221 -
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
|
Phase 3 | |
Completed |
NCT02057315 -
Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
|
Phase 1/Phase 2 | |
Completed |
NCT00109083 -
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
|
Phase 2 | |
Completed |
NCT02098499 -
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the Emergency Department: A Randomized Controlled Trial
|
Phase 4 | |
Completed |
NCT00714727 -
Set Point Acupuncture for Migraines Using a Digital Assistant
|
Phase 1 | |
Completed |
NCT00434083 -
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
|
Phase 3 | |
Completed |
NCT00960245 -
Relative Bioavailability Study of Nadolol (1 x 80 mg) Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT02856802 -
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
|
Phase 2 | |
Completed |
NCT00355056 -
PREMIUM Migraine Trial
|
N/A | |
Completed |
NCT01118988 -
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
|
N/A | |
Completed |
NCT00433732 -
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
|
Phase 3 | |
Completed |
NCT00750594 -
Patent Foramen Ovale in Children With Migraine Headaches
|
N/A |